A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...

By Bhanvi Satija and Pushkala Aripaka LONDON, Feb 4 (Reuters) - GSK's new CEO Luke Miels said on Wednesday that the drugmaker ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...

DS-9606 was supposed to be the first antibody-drug conjugate in Daiichi Sankyo’s line of anti-cancer assets to use a modified ...

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...

Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like ...

Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

Regarding the industry's talent pipeline, Dr. de Miguel highlights the importance of education programs in the fields of science, technology, engineering, and mathematics (STEM) in building the ...

As India’s pharmaceutical industry moves towards becoming a 500 billion dollars global powerhouse by 2047, a new report highlighted the growing role of non-animal, science-driven testing methods in ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

A major step towards simpler drug development has been taken at the University of Gothenburg. In a new study, researchers have developed stable boron-fluorine compounds that make it possible to ...

In a year from now, progress is to be measured in the institutionalisation of the approach with greater regulatory acceptance ...